3380.HK - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 20/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 2.4x as much as the broader market.

Beta (Market Relation)

2.4x

Above average

Volatility (5Y p.a.)

88.2% p.a.

5-Year Horizon

Max Drawdown (5Y)

-96.3%

5-Year Horizon

Sharpe Ratio

-0.39

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-8.1%
3 Years	60.5%	-49.3%	0.25	+17.3%
5 Years	88.2%	-96.3%	-0.39	-32.4%
10 Years	68.6%	-97.9%	-0.18	-9.6%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 429%.

Unprofitable business model: The company is currently generating net losses.

High market risk: Beta of 2.40 indicates above-average volatility compared to the broader market.

Strong cyclicality: The business model is sensitive to economic downturns.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (88.2% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -97.9% in the extended horizon.